OBJECTIVE: To identify causes of the autosomal-recessive malformation, diencephalic-mesencephalic junction dysplasia (DMJD) syndrome. METHODS: Eight families with DMJD were studied by whole-exome or targeted sequencing, with detailed clinical and radiological characterization. Patient-derived induced pluripotent stem cells were derived into neural precursor and endothelial cells to study gene expression. RESULTS: All patients showed biallelic mutations in the nonclustered protocadherin-12 (PCDH12) gene. The characteristic clinical presentation included progressive microcephaly, craniofacial dysmorphism, psychomotor disability, epilepsy, and axial hypotonia with variable appendicular spasticity. Brain imaging showed brainstem malformations and with frequent thinned corpus callosum with punctate brain calcifications, reflecting expression of PCDH12 in neural and endothelial cells. These cells showed lack of PCDH12 expression and impaired neurite outgrowth. INTERPRETATION: DMJD patients have biallelic mutations in PCDH12 and lack of protein expression. These patients present with characteristic microcephaly and abnormalities of white matter tracts. Such pathogenic variants predict a poor outcome as a result of brainstem malformation and evidence of white matter tract defects, and should be added to the phenotypic spectrum associated with PCDH12-related conditions. Ann Neurol 2018;84:646-655.
OBJECTIVE: To identify causes of the autosomal-recessive malformation, diencephalic-mesencephalic junction dysplasia (DMJD) syndrome. METHODS: Eight families with DMJD were studied by whole-exome or targeted sequencing, with detailed clinical and radiological characterization. Patient-derived induced pluripotent stem cells were derived into neural precursor and endothelial cells to study gene expression. RESULTS: All patients showed biallelic mutations in the nonclustered protocadherin-12 (PCDH12) gene. The characteristic clinical presentation included progressive microcephaly, craniofacial dysmorphism, psychomotor disability, epilepsy, and axial hypotonia with variable appendicular spasticity. Brain imaging showed brainstem malformations and with frequent thinned corpus callosum with punctate brain calcifications, reflecting expression of PCDH12 in neural and endothelial cells. These cells showed lack of PCDH12expression and impaired neurite outgrowth. INTERPRETATION: DMJD patients have biallelic mutations in PCDH12 and lack of protein expression. These patients present with characteristic microcephaly and abnormalities of white matter tracts. Such pathogenic variants predict a poor outcome as a result of brainstem malformation and evidence of white matter tract defects, and should be added to the phenotypic spectrum associated with PCDH12-related conditions. Ann Neurol 2018;84:646-655.
Authors: Mary C O'Driscoll; Sarah B Daly; Jill E Urquhart; Graeme C M Black; Daniela T Pilz; Knut Brockmann; Meriel McEntagart; Ghada Abdel-Salam; Maha Zaki; Nicole I Wolf; Roger L Ladda; Susan Sell; Stefano D'Arrigo; Waney Squier; William B Dobyns; John H Livingston; Yanick J Crow Journal: Am J Hum Genet Date: 2010-08-19 Impact factor: 11.025
Authors: Maha S Zaki; Sahar N Saleem; William B Dobyns; A James Barkovich; Hauke Bartsch; Anders M Dale; Manzar Ashtari; Naiara Akizu; Joseph G Gleeson; Ana Maria Grijalvo-Perez Journal: Brain Date: 2012-07-20 Impact factor: 13.501
Authors: C Marini; D Mei; L Parmeggiani; V Norci; E Calado; A Ferrari; A Moreira; T Pisano; N Specchio; F Vigevano; D Battaglia; R Guerrini Journal: Neurology Date: 2010-08-17 Impact factor: 9.910
Authors: Leanne M Dibbens; Patrick S Tarpey; Kim Hynes; Marta A Bayly; Ingrid E Scheffer; Raffaella Smith; Jamee Bomar; Edwina Sutton; Lucianne Vandeleur; Cheryl Shoubridge; Sarah Edkins; Samantha J Turner; Claire Stevens; Sarah O'Meara; Calli Tofts; Syd Barthorpe; Gemma Buck; Jennifer Cole; Kelly Halliday; David Jones; Rebecca Lee; Mark Madison; Tatiana Mironenko; Jennifer Varian; Sofie West; Sara Widaa; Paul Wray; John Teague; Ed Dicks; Adam Butler; Andrew Menzies; Andrew Jenkinson; Rebecca Shepherd; James F Gusella; Zaid Afawi; Aziz Mazarib; Miriam Y Neufeld; Sara Kivity; Dorit Lev; Tally Lerman-Sagie; Amos D Korczyn; Christopher P Derry; Grant R Sutherland; Kathryn Friend; Marie Shaw; Mark Corbett; Hyung-Goo Kim; Daniel H Geschwind; Paul Thomas; Eric Haan; Stephen Ryan; Shane McKee; Samuel F Berkovic; P Andrew Futreal; Michael R Stratton; John C Mulley; Jozef Gécz Journal: Nat Genet Date: 2008-05-11 Impact factor: 38.330
Authors: Sayantanee Biswas; Michelle R Emond; Phan Q Duy; Le T Hao; Christine E Beattie; James D Jontes Journal: Mol Biol Cell Date: 2013-12-26 Impact factor: 4.138
Authors: Raymond A Sobel; Mary Jane Eaton; Prajakta Dilip Jaju; Eugene Lowry; Julian R Hinojoza Journal: J Neuropathol Exp Neurol Date: 2019-09-01 Impact factor: 3.685